Sign In to Follow Application
View All Documents & Correspondence

Synergistic Herbal Composition And Method Of Prepration Thereof For Treatment Of Hepatitis B/C, Jaundice Cancer And Hiv

Abstract: The invention relates to a synergic herbal composition for treatment of Hepatitis B, Hepatitis C, Jaundice Cancer and HIV and a process of preparing said herbal composition. The synergic composition comprises oldenlandia corymbosa, hedyotis corymbosa, hedyotis diffusa or oldenlandia diffusa with a sugar content and has the effects of inhibiting inflammatory, improving the liver function, protecting the liver. The composition can be used for treating liver-qi invasion, pathogenic dampness and spleen encumbering and syndromes of viral hepatitis type b/c, Jaundice cancer as well as HIV and cancer virus. The preparation has the advantages of quick effect, high bioavailability, convenience in carrying and the like.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
03 May 2019
Publication Number
21/2019
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
balram.bme@gmail.com
Parent Application

Applicants

PRAHLAD SINGH
S/o Shri Shyamlal, Village- Ratanpur, P.O.- Keshar Kelan , Block + Tahshil- Dibai, District- Bulandshahar (U.P), INDIA , Pin-202393

Inventors

1. PRAHLAD SINGH
S/o Shri Shyamlal, Village- Ratanpur, P.O.- Keshar Kelan , Block + Tahshil- Dibai, District- Bulandshahar (U.P), INDIA , Pin-202393

Specification

FIELD OF INVENTION
The invention relates to a synergistic herbal composition for the treatment of Hepatitis B, Hepatitis C, Cancer and HIV and a process of preparing said herbal composition.
The invention belongs to the field of medical technology, in particular relates to a synergistic herbal composition medicine for the treatment of liver related disease of human being.
The invention is also relates to a technical field of herbal medicine, in particular relates to a herbal medicine composition for the treatment of chronic diseases like hepatitis B/C, ADDS, jaundice and Cancer
The invention is also related to the field of 'synergic herbal composition preparations'. The invention is also belong to the field of anti-cancer a synergistic herbal composition medicine and discloses an anti-cancer herbal composition medicines and preparation of method thereof.
BACKGROUND & PRIOR ART
The liver is the largest solid organ and the largest gland in the h,man body. It is located in the right upper quadrant of the abdomen, below the diaphragm. Its other roles in metabolism include the regulation of glycogen storage, decomposition of red blood cells and the production of hormones. The liver is an accessory digestive gland that produces bile, an alkaline compound which helps the breakdown of fat. Bile aids in digestion via the emulsification of lipids.

According to the American liver Foundation , the liver related diseases are Alagille Syndrome, Alcohol-Related Liver Disease, Alpha-1 Antitrypsin Deficiency, Autoimmune Hepatitis, Benign Liver Tumors, Biliary Atresia , Cirrhosis, Crigler-Najjar Syndrome, Galactosemia, Gilbert Syndrome, Hemochromatosis, Hepatitis A, Hepatitis B, Hepatitis C,Hepatic Encephalopathy, Intrahepatic Cholestasis of Pregnancy (ICP), Lysosomal Acid Lipase Deficiency (LAL-D), Liver Cysts, Liver Cancer,Newborn Jaundice Non-Alcoholic Fatty Liver Disease, Primary Biliary Cholangitis (PBC),Primary Sclerosing Cholangitis (PSC), Reye Syndrome, Type I Glycogen Storage Disease and Wilson Disease,
Chronic hepatitis is composed of a plurality of acute hepatitis b, acute hepatitis c long time, and the course of disease for more than half a year, and to chronic hepatitis. There are also many patients after hepatitis virus infection, misprision out, has become chronic hepatitis when found.
Jaundice for various reasons (a, b, hepatitis c virus, intoxicants, drugs and the like) for the role of the liver hepatocyte denatured, destroyed, necrosis, liver cell and fiber tissue reconstruction, causing the blood bilirubin rise, skin mucosa H§£, urine yellow such as te. Jaundice is one of the clinical common diseases in card, can be seen in western medicine a plurality of hepatobiliary disorders, especially hepatitis b rare.
Some of the prior works are as follows:
CN102048858A "Medicine composition for treating cirrhosis, hepatic ascites and liver cancer" present a Chinese material medical preparation comprising total saponin of American ginseng, tanshinone II a, total saponin of the root of Chinese thorowax, total lignan of the fruit of Chinese magnoliavine, giant knot weed alcohol extract, oldenlandia diffusa alcohol extract, bear gall and ovelecithin. The Chinese material medical preparation is used for treating cirrhosis, hepatic ascites and liver cancer. The Chinese material medical preparation is used for treating cirrhosis and hepatic ascites with cure rate reaching 80 percent and effective rate reaching 95 percent through strengthening

the body resistance, tonifying qi and yin, promoting blood circulation and removing blood stasis, clearing heat and detoxicating, inhibiting tumors and resisting hepatic fibrosis, and treating the liver cancer with cure rate reaching 60 percent and effective rate reaching 80 percent.
CN1201682A - Pills for cancers and hepatitis B and C and preparation thereof present A medical pill for preventing and curing cancers and hepatitides B and C is prepared from 8 Chinese-medicinal materials such as peach kernel, bitter apricot kernel, gingko seed, barbat skullcap, oldenlandia,etc. and features high curative effect, no toxic by-effect, low cost and long storage period.
CN1109710A - Health tea containing Cephalotaxus fortunei and preparing process thereof present a health-care tea is made up of Cephalotaxus fortunei, Japanese pyrola, isatis root, oldenlandia and green tea through parching, stirring, breaking, and bagging, and has medical functions of preventing and curing cancer, common cold, hepatitis A and B, lumbago and rheumatalgia.
CN104800776A - Traditional Chinese medicine composition for treating alcoholic hepatic fibrosis present a a traditional Chinese medicine composition for treating alcoholic hepatic fibrosis. The traditional Chinese medicine composition is prepared from the following medicinal components: dandelion, kelp, oldenlandia diffusa, abrus cantoniensis hance, radix paeonia, root of red-rooted salvia, curcuma zedoary, medicated leaven, fructus amomi and root of kudzu vine. The traditional Chinese medicine composition for treating the alcoholic hepatic fibrosis is reasonable in composition, easy to prepare and has remarkable curative effects of activating spleen and dispelling the effects of alcohol.
CN101695562B - A traditional Chinese medicine for treating viral hepatitis composition and method of making the same present a a Chinese medicinal composition for the treatment of viral hepatitis and its preparation method, the traditional Chinese medicine composition is composed of the following raw materials: baihuasheshecao 15-45 parts, barbed skullcap 15-45 parts, radix isatidis 15-45 parts, burnt largehead atractylode 5-15 parts, radix

salviae Miltiorrhizae 8-22 parts, Curcuma aromatica 8-22 parts, licorice 3-9 parts, Japanese knotweed 5-15 parts, Magnolia bark 5-15 parts, COiX seed 8-22 parts, Breit 5-15 parts, myristoyl 3-9 parts, Patrinai villosa 10-30 parts.
CN100350955C - Chinese traditional medicine preparation of linearstripe rabdosia herb granule with ten kinds for treating present herb granule preparation and its preparation method, preparation to herb, Phyllanthus emblica, baihuasheshecao, Artemisia capillaris, Rhizoma Atractylodis Macrocephalae, Poria (Indian bread), microcos, valley bud, malt and radix Bupleuri as raw materials, protective circuit Artemisia capillaris, Rhizoma Atractylodis Macrocephalae, radix Bupleuri by a steam distillation method for extracting volatile oil, residues and the remaining seven taste after boiling water mix decoctions, filtering, the filtrate is concentrated under reduced pressure the resulting extract.
Batasa I Sugar Drop Candy is a very popular India . Specially in Hindu Festival it is a must have sweet. It is preprared with following steps:
1. In a small saucepan, place sugar and water over a medium heat until the sugar is dissolved.
2. Bring sugar, syrup and water to the boil and simmer for 5 minutes. When white bubbles start to show from bottom, stir constantly.
3. Place aluminium foil close to the stove and remove the saucepan from the heat. Add the bicarbonate soda to the saucepan.
4. Pour spoonful hot mixture on foil till you finish the mixture (you need to be quick)and leave to cool.
5. Prepared Batasa I Sugar Drop Candy which has long shelf life.

Groupings of alternative elements or embodiments of the invention disclosed herein are not to be construed as limitations. Each group member can be referred to and claimed individually or in any combination with other members of the group or other elements found herein.
One or more members of a group can be included in, or deleted from, a group for reasons of convenience and/or patentability. When any such inclusion or deletion occurs, the specification is herein deemed to contain the group as modified thus fulfilling the written description of all Markus groups used in the appended claims.
As used in the description herein and throughout the claims that follow, the meaning of "a," "an," and "the" includes plural reference unless the context clearly dictates otherwise. Also, as used in the description herein, the meaning of "in" includes "in" and "on" unless the context clearly dictates otherwise.

The recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range. Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. "such as") provided with respect to certain embodiments herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
All publications herein are incorporated by reference to the same extent as if each individual publication or patent application were specifically and individually indicated to be incorporated by reference. Where a definition or use of a term in an incorporated reference is inconsistent or contrary to the definition of that term provided herein, the definition of that term provided herein applies and the definition of that term in the reference does not apply.
OBJECTIVE OF THE INVENTION
The principle objective of the present invention is to present an synergistic herbal composition for treatment of hepatitis-B/C, jaundice cancer and HIV.
The present invention is also related to method of preparation of an synergistic herbal composition and method of preparation thereof for treatment of hepatitis-B/C, jaundice cancer and HIV.

SUMMARY
A synergistic herbal composition for the treatment of Hepatitis B, Hepatitis C, Jaundice Cancer or HIV is presented. The synergistic herbal composition which is characterized in that the pharmaceutical raw materials in parts by weight: 100-1000 parts of a herbal plant selected from list consisting oldenlandia corymbosa, Hedyotis corymbosa, Hedyotis diffusa or Oldenlandia diffusa; and 10-100 parts of a sugar content material..
A method for preparation of synergistic herbal composition for the treatment of Hepatitis B, Hepatitis C, Jaundice, Cancer or HIV is present in this disclosure. The method comprising steps of washing and drying the bark of the herbs in air, selected from the list selected from list consisting oldenlandia corymbosa, Hedyotis corymbosa, Hedyotis diffusa or Oldenlandia diffusa; pounding of the herb; mixing said herb in with a sugar content material; and heating said above mixture with 10 to 50 times weight of water in a metal container, at temperature of 30-110°C till water evaporates andl/2 to 1/8 water remained.
DETAIL DESCRIPTION
The herb oldenlandia corymbosa is used in the present disclosure. It is also known as Hedyotis brachypoda R.Br, ex Wall., nom. nud., Hedyotis diffusa Willd., Hedyotis diffusa var. extensa (Hook.f) R.Dutta, Hedyotis extensa R.Br, ex Wall., nom. nud. , Hedyotis polygonoides Wall., nom. nud. Hedyotis radicans Bartl. ex DC, nom. nud. , Hedyotis ramosissima Kurz, nom. illeg., Oldenlandia angustifolia var. pedicellata Miq., Oldenlandia brachypoda G.Don, nom. illeg., Oldenlandia corymbosa var. uniflora (Benth.) Masam., Oldenlandia diffusa var. extensa Hook.f, Oldenlandia diffusa var. polygonoides Hook.f. , Oldenlandia herbacea var. uniflora Benth., Oldenlandia pauciflora Roxb. ex Wight & Arn.

Muscovado, also khandsari and khand, is a type of partially refined to unrefined sugar with a strong molasses content and flavour. It is technically considered either a non-centrifugal cane sugar or a centrifuged, partially refined sugar according to the process used by the manufacture Muscovado contains higher levels of various minerals than processed white sugar, and is considered by some to be healthier Its main uses are in food and confectionery, and the manufacture of rum and other forms of alcohol. The largest producer and consumer of muscovado is India.
EXAMPLE:
DOSAGE:
Adults: One spoon of 2-3 gms. of the herbal composition with 2 spoons of
lukewarm water, twice daily
Children: One spoon of 1-2 gms. of the herbal composition with 2 spoons of
lukewarm water, twice daily.
The dosage is varies from patient to patient & conditions of the disease of the
patient.
CONTROL OF FOOD OF PATIENT
Patient can eat golden gram, gourd, tomai, wheat flour, and Sugarcane. The patient need to minimize intake of Cumin, salt and chilly. No other food is also during treatment of the patient.

RESULT
Some of the results of the patients are listed herewith.

We claim:
1. A synergistic herbal composition for the treatment of Hepatitis B, Hepatitis C, Jaundice Cancer or HIV, which is characterized in that the pharmaceutical raw materials in parts by weight: 100-1000 parts of a herbal plant selected from list consisting oldenlandia corymbosa, Hedyotis corymbosa, Hedyotis diffusa or Oldenlandia diffusa; and 5-100 parts of a sugar content material.
2. The synergistic herbal composition for the treatment of Hepatitis B, Hepatitis C, Jaundice Cancer or HIV as claimed in the claim 1 , the sugar content material is selected from but not limited to a batasa, a khand or honey.
3. A method for preparation of synergistic herbal composition for the treatment of Hepatitis B, Hepatitis C, Jaundice, Cancer or HIV, comprising steps of:
washing and drying the bark of the herbs in air, selected from the list selected from list consisting oldenlandia corymbosa, Hedyotis corymbosa, Hedyotis diffusa or Oldenlandia diffusa;
pounding of the herb;

mixing said herb in with a sugar content material; and
heating said above mixture with 10 to 50 times weight of water in a metal container, at temperature of 30-110°C till water evaporates andl/2 to 1/8 water remained.
4. The method for preparation of synergistic herbal composition for the treatment of Hepatitis B, Hepatitis C, Jaundice, Cancer or HIV as claimed in the claim 3 , the sugar content material is selected from but not limited to a batasa, a khand or honey.
5. The method for preparation of synergistic herbal composition for the treatment of Hepatitis B, Hepatitis C, Jaundice, Cancer or HIV as claimed in the claim 3 , the a metal container is a steel metal container.

Documents

Application Documents

# Name Date
1 201911017851-Others-030325.pdf 2025-03-12
1 201911017851-STATEMENT OF UNDERTAKING (FORM 3) [03-05-2019(online)].pdf 2019-05-03
2 201911017851-REQUEST FOR EARLY PUBLICATION(FORM-9) [03-05-2019(online)].pdf 2019-05-03
2 201911017851-Form 13-170225.pdf 2025-02-27
3 201911017851-Others-170225.pdf 2025-02-27
3 201911017851-FORM-9 [03-05-2019(online)].pdf 2019-05-03
4 201911017851-FORM 1 [03-05-2019(online)].pdf 2019-05-03
4 201911017851-Form-13-010523.pdf 2023-05-04
5 201911017851-Form-18-010523.pdf 2023-05-04
5 201911017851-DECLARATION OF INVENTORSHIP (FORM 5) [03-05-2019(online)].pdf 2019-05-03
6 201911017851-COMPLETE SPECIFICATION [03-05-2019(online)].pdf 2019-05-03
6 201911017851 Correspondence from NBA(18-09-2019).pdf 2019-09-18
7 201911017851-COMPLETE SPECIFICATION [03-05-2019(online)].pdf 2019-05-03
7 201911017851 Correspondence from NBA(18-09-2019).pdf 2019-09-18
8 201911017851-REQUEST FOR EARLY PUBLICATION(FORM-9) [03-05-2019(online)].pdf 2019-05-03
8 201911017851-Form-18-010523.pdf 2023-05-04
8 201911017851-DECLARATION OF INVENTORSHIP (FORM 5) [03-05-2019(online)].pdf 2019-05-03
9 201911017851-STATEMENT OF UNDERTAKING (FORM 3) [03-05-2019(online)].pdf 2019-05-03
9 201911017851-Form-13-010523.pdf 2023-05-04
9 201911017851-FORM 1 [03-05-2019(online)].pdf 2019-05-03
10 201911017851-FORM-9 [03-05-2019(online)].pdf 2019-05-03
10 201911017851-Others-170225.pdf 2025-02-27
11 201911017851-Form 13-170225.pdf 2025-02-27
11 201911017851-REQUEST FOR EARLY PUBLICATION(FORM-9) [03-05-2019(online)].pdf 2019-05-03
12 201911017851-STATEMENT OF UNDERTAKING (FORM 3) [03-05-2019(online)].pdf 2019-05-03
12 201911017851-Others-030325.pdf 2025-03-12
13 201911017851-Correspondence-100625.pdf 2025-06-17
14 201911017851-Others-1-040725.pdf 2025-07-10
14 201911017851-FORM-13.pdf 2025-07-04
15 201911017851-Others-040725.pdf 2025-07-10
16 201911017851-Correspondence-040725.pdf 2025-07-10
17 201911017851-Correspondence-18-08-2025.pdf 2025-08-18